PPARG and Familial prostate cancer: However, other studies showed that the antiproliferative effects of γ-tocotrienol in prostate cancer cells result from PPARγ-dependent mechanisms associated with increased synthesis of the PPARγ endogenous ligand, 15-HETE [8].